Following back-to-back eight-IPO weeks, the IPO market is taking a breather with just one IPO scheduled for the week ahead. That said, several companies could launch on Monday to price later in the week.
Pharmaceutical royalty acquirer Royalty Pharma (RPRX) plans to raise $1.9 billion at a $15.8 billion market cap. The company is the global leader in pharma royalty agreements, with an estimated 50%+ historical market share, and has spent over $18 billion on royalty acquisitions since its inception to build a diverse portfolio of marketed and late-development-stage therapies. Royalty Pharma is highly profitable